Senior Staff Bioinformatics Scientist
Illumina
Senior Staff Bioinformatics Scientist
Illumina
Develops sequencing platforms and consumables
Why us
Illumina is the global leader in Next Generation Sequencing (NGS) technology. Through relentless innovation, Illumina has reduced the cost of sequencing a human genome from hundreds of thousands of dollars to below $200. The drastic cost reduction has moved NGS from the laboratory to the clinic, with wide-ranging impact from cancer diagnostics to genetic testing. We invite you to join us in our effort to improve human health by unlocking the power of the genome.
Position summary
We are seeking a Senior Staff Scientist to help build computational tools and data foundation for our protein engineering group across global enzyme engineering programs. This role will connect data structures for high-throughput and mid-throughput screening, participate in method development and evaluation, and help establish semi-closed-loop and closed-loop design-build-test-learn workflows.
The successful candidate will provide senior technical leadership at the interface of protein engineering, AI/ML design, screening data systems, automation, and experimental execution. This scientist will define how screening results become reusable data assets as well as how computational methods are benchmarked and adopted.
The role is based in Singapore. This is an exciting opportunity to be a part of Illumina’s continued growth.
Responsibilities include, but are not limited to:
All listed tasks and responsibilities are deemed as essential functions to this position; however, business conditions may require reasonable accommodations for additional task and responsibilities.
Education, Experience & Attributes required:
Preferred experiences and attributes
Illumina develops and sells integrated sequencing systems and the consumables needed to analyze genetic variation and biological function. Its instruments use sequencing-by-synthesis on flow-cell-based platforms, with specialized reagents and library preparation kits that are consumed per run. The company differentiates itself through a broad end-to-end ecosystem, a large installed base that drives repeat purchases, and strategic acquisitions that expand capabilities into multiomics and clinical applications. Its goal is to advance genomic analysis for research and clinical diagnostics to enable personalized medicine and early cancer detection.
Explore more opportunities at Illumina